Benzinga | Apr 7, 2021 07:31AM EDT

Bausch + Lomb Receives FDA Approval For ClearVisc Dispersive Ophthalmic Viscosurgical Device

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (TSX:BHC) ("Bausch Health"), today announced that the U.S. Food and Drug Administration (FDA) has approved ClearVisc(tm) dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery.